Cure My Disease

Don't miss your cure!

 Log in / Sign up

Lab-Grown skin could transform burn healing

NCT ID NCT06745557

Recruiting now ⭐️ CURE ⭐️ Sponsor: CUTISS AG Source: ClinicalTrials.gov ↗

First seen Aug 10, 2026 · Last updated Aug 11, 2026 · Updated 1 time

Summary

This trial tests an engineered skin graft called denovoSkin™, made from a patient's own skin cells, for treating deep burns. It aims to see if this graft can close wounds and reduce scarring better than the standard split-thickness skin graft. The study includes adults and adolescents aged 12 and older with burns covering at least 20% of their body. Each participant receives both treatments on different burn areas to compare outcomes directly.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
denovoSkin™, an engineered skin graft made from the patient's own skin cells
What this could lead to
If successful, denovoSkin™ could offer a more effective way to close severe burn wounds, potentially reducing scarring and improving recovery for burn patients.
What could go wrong
This is a phase III trial, so while promising, it may not confirm the expected benefits. Risks include graft failure, infection, or scarring that is not better than standard treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BURNS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

burn severe cutaneous adverse reaction

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BURNS

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

Locations

  • AOU Padova

    NOT_YET_RECRUITING

    Padova, 35128, Italy

  • Azienda Ospedaliera di Rilievo Nazionale A. Cardarelli

    RECRUITING

    Naples, 80131, Italy

  • BG Klinikum Bergmannstrost Halle

    RECRUITING

    Halle, 06112, Germany

  • BG Klinikum Unfallkrankenhaus Berlin

    RECRUITING

    Berlin, 12683, Germany

  • BG-Unfallklinik Murnau

    RECRUITING

    Murnau am Staffelsee, 82418, Germany

  • CHU de Liège Département de pharmacie hospitalière - Secteur Essais cliniques

    RECRUITING

    Liège, B-4000, Belgium

  • Centre Hospitalier Universitaire de Montpellier

    RECRUITING

    Montpellier, 34295, France

  • Hopital Edouard Herriot Centre des Brûlés de Lyon

    RECRUITING

    Lyon, 69003, France

  • Hospital Universitario La Paz Edificio Traumatología

    RECRUITING

    Madrid, 28046, Spain

  • Hospital Universitario Vall d'Hebron

    RECRUITING

    Barcelona, 08035, Spain

  • Hospital Universitatrio y Politécnico La Fe

    RECRUITING

    Valencia, 46026, Spain

  • Maasstad Hospital Dep. Burn Wound Centre

    RECRUITING

    Rotterdam, 3079 DZ, Netherlands

  • Medizinische Hochschule Hannover

    NOT_YET_RECRUITING

    Hanover, 30625, Germany

  • Pharmacie Hôpital Conception

    RECRUITING

    Marseille, 13005, France

  • Rode Kruis Ziekenhuis

    RECRUITING

    Beverwijk, 1942, Netherlands

  • Samodzielny Zakład Opieki Zdrowotnej z siedzibą w Łęcznej

    RECRUITING

    Łęczna, 21-010, Poland

  • Santobono-Pausilipon

    RECRUITING

    Naples, 80129, Italy

  • Unidade de Queimados do CHUC

    RECRUITING

    Coimbra, 3000-075, Portugal

  • Universtitätsspital Zürich

    RECRUITING

    Zurich, 8091, Switzerland

More trials for these conditions

Other studies related to the condition(s) this trial covers.